Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion type Assertion NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_head.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion description "[Sections of 51 brain-invasive meningiomas (31 meningothelial meningiomas WHO grade I, 11 atypical WHO grade II, and nine anaplastic WHO grade III tumours) were immunolabelled with antibodies against SPARC, epithelial membrane antigen (EMA), collagen IV and glial fibrillary acidic protein (GFAP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_provenance.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion evidence source_evidence_literature NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_provenance.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion SIO_000772 16972886 NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_provenance.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion wasDerivedFrom befree-2016 NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_provenance.
- NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_assertion wasGeneratedBy ECO_0000203 NP569324.RAVZ9B_1Bkh1Fl5vNjAdcWxMjxdUJ6PBH94x715BEqYD0130_provenance.